Alzheimer's with Ralph Sanchez

As years pass by, the number of people with Alzheimer's increases. That's why medical experts are researching and studying the possible causes. In this episode of Medical Insider, Ralph Sanchez and I talk about why women are more prone to dementia than men, approaches and exercises that can help you with Alzheimer's, and many more!

More information on Ralph Sanchez, his books and his BrainDefend® Body-Brain Renewal programs are available at www.TheAlzheimersSolution.com and BrainDefend.com

Stay tuned for more exciting and insightful episodes! Follow and subscribe to our podcast using the links below ⏬⏬⏬ 

Website: https://themedicalinsider.buzzsprout.com/
Apple Podcast: https://apple.co/3FVK4IU
Spotify: https://spoti.fi/3NkufxH
Youtube: https://bit.ly/3lnlbMo

Transcript

Intro
Welcome to "The Medical Insider" podcast, where we highlight real-life solutions to your health challenges, encorporate new technology and proven solutions from the past with a healthy dose of common sense while resisting the pitfalls of idiopathic classifications and economically-based medical doctrine. This is your host, Dr. Thomas Santucci. Let's get started.

Dr. Thomas Santucci
I want to welcome Ralph Sanchez, who is a friend of mine. He's a person that I've worked with for a dozen or so years and has an elegant touch in the clinical nutrition world and has now entered into the neurocognitive realm and added his expertise. He's got a book out "The Diabetic Brain in Alzheimer's Disease". And this is a timely subject because as most of our listeners know that the neurocognitive stuff has really been relegated to the, you know, can't figure it out, can't fix it, can't do much about it world, and we just don't believe that. So we actually believe that there's always something to be done, and if the devil's in the details, and that's where we have to go. But there has to be some kind of way to put order on this. So, you know, Ralph and I were just saying we don't want to have to do everything about everything, especially with a person that can't eat with a spoon. Some of the statistics on Alzheimer's are just scary. There are more than six million people with Alzheimer's right now. And the problem with this is it's a little bit like diabetes, is that these numbers are getting worse. It's not like the steady state and cardio and in oncology where we're just not making any progress. We're actually going backward on this. So seven million by the year 2030, and then 14 million, which is a lot of people to take care of by 2050. That number goes up and down, but it's between 12 and a half and 14 million. It's projected that this will cost $321 billion in national health care for people with Alzheimer's and the neurocognitive dementia. So when we're looking at the national debt, one of the big things that you can actually do is look at, you know, where you're spending money and what's going to cost us what. And this has a huge price tag. People will care about this. Plus, 55% of primary care physicians say there are not enough dementia care specialists in their communities to meet the patient demands. That means you, your sister, your brother, and your kids will be taking care of somebody with Alzheimer's or dementias. And so this is a subject that we're probably ten years ahead of the ball, bu that's where we like to be. And it's a subject that really, truly says, you know, the preventative part of this is the key. So with that, I want to welcome Ralph and, you know, get right into it. And basically, what do you feel is the main reason? Like, on a macro level? I know there are a lot of little reasons, but why is there this dramatic increase in Alzheimer's? What's going on?

Ralph Sanchez
Well, first of all, thank you, Thomas, for inviting me on. It's a real pleasure to be here on "The Medical Insider" with you. To answer your question, I realized many, many years ago, I started my research on the topic in the late 90s that was inspired by the understanding of several risk factors associated with Alzheimer's disease that I saw in myself. I was personally motivated--

Dr. Thomas Santucci
Yeah. There you go.

Ralph Sanchez
To learn more about this. And the more I learned about it, especially discovering the APOE4 genetic variant that's associated with late-onset Alzheimer's disease as a risk factor and how that was connected to cardiovascular disease. So, when I saw that and started to realize some of the risk factors that I had, I said, this is really a rich subject that I think is going to explode in 10, 15 years. And indeed it did.

Dr. Thomas Santucci
Right.

Ralph Sanchez
Because back then, nobody was talking about prevention. Nobody was talking about any treatments whatsoever having to do with addressing the issue of cognitive decline. Of course, in functional medicine, we always talk about potential answers related to lifestyle and nutrition. People don't understand that Alzheimer's disease has at least a 20 to 30-year disease trajectory.

Dr. Thomas Santucci
That's interesting. I've always heard ten. So, that's amazing.

Ralph Sanchez
Yeah. Oh, no, 20 to 30 years, at least. As a matter of fact, a recent study was published recently where a doctor made a case through a study that if you looked at your cardiovascular risk factors in your 30s, those were highly associated. And this is no secret.

Dr. Thomas Santucci
Right.

Ralph Sanchez
I'll never forget running under the term cardiogenic dementia, which was coined back in 1977.

Dr. Thomas Santucci
I like it. Yeah.

Ralph Sanchez
Yeah. And so this doctor obviously, had seen much of that research because it's been going on for literally almost 40 years.

Dr. Thomas Santucci
Right.

Ralph Sanchez
And he described the typical risk factors associated with cardiovascular disease, you know, oxidation of cholesterol, triglycerides, you know, cardiometabolic problems associated with the early onset of diabetes and cardiovascular disease. And he said those risk factors in your 30s are highly associated with the risk for dementia later in life.

Dr. Thomas Santucci
See, that's so amazing because the number one killer of human beings is on Earth, and said it's important to get early testing on it. And, oh, by the way, you know, not only will it probably keep you alive and make you aware of what the real deficits in health are, but it will protect your brain and getting a twofer like that. One of the big things I have is, as my Don Quixote, you know, kill the windmill thing, is that I want to change the standard of practice. I want to change what general practitioners do, and I want to change what specialists do because it's absurd. And so, now, if you go to your guy every three years and you get that kind of testing, and you get the real cardiac testing, and it's getting better and better all the time, you know, like serum calcium and that kind of thing is now predicted for heart disease. If we got the real testing, you're saying that that would correlate well, not just as some kind of, like, amorphous thing, but directly with dementia.

Ralph Sanchez
Oh, absolutely. And that's the case that I make pretty convincingly, if I might say, in my book.

Dr. Thomas Santucci
Yeah. I saw that. I like that in your book. Yeah.

Ralph Sanchez
Yeah. No, diabetes-- and you talked about the rates of Alzheimer's, the late-onset Alzheimer's disease, particularly.

Dr. Thomas Santucci
Right.

Ralph Sanchez
And that was one of the eye-openers that I had early on because back in the early 2000s, they were already talking about the rates tripling over the next 30 to 40 years. I saw that. And of course, you know, and you spoke about all the financial implications.

Dr. Thomas Santucci
Yeah, it's going to be huge, because, I mean, in this kind of self-oriented world we're living in these days, in the post-Covid, nobody can pay attention to anything that's not right in front of your face. This is going to be right in front of your face. This is going to be, Aunt Martha can't feed herself, or she just took the car and she doesn't know how to drive, you know.

Ralph Sanchez
Absolutely. So even that part about it, an important aspect in planning.

Dr. Thomas Santucci
Right.

Ralph Sanchez
You know, looking at your future and the future of your relatives, particularly your parents. You know, if there's any history of dementia or Alzheimer's in the family, you really want to be looking ahead very seriously at what might possibly evolve into a situation that may be very difficult for you to manage.

Dr. Thomas Santucci
Oh, yeah. So, we've got the cardiac testing, and that's pretty straightforward, although I'm sure that there are nuances. What do you think about, like, the 23andMe kind of Amyloid beta testing and the genetic predisposition marker testing?

Ralph Sanchez
You know, there are so many core genes that are associated with metabolism, and cardiovascular disease, right?

Dr. Thomas Santucci
Right.

Ralph Sanchez
And diabetes. That is a great place to start.

Dr. Thomas Santucci
Okay.

Ralph Sanchez
And having that interpreted through a good resource and having a practitioner be able to apply that for you in terms of a comprehensive risk assessment that includes biochemical and metabolic risk factors that will look deeply into your particular-- your personalized risk for a particular disorder, particularly Alzheimer's disease or dementia.

Dr. Thomas Santucci
Ralph, you're getting dangerously close to the deep dives we used to do 20 years ago, I mean, you're really dating yourself here. But I think it's crucial. I mean, we need somebody who is going to take more than a cursory look at this. And there are two groups of people that always amaze me. Anyone who can lift up a film and go, yes, looks great. I've never seen a film in my life that looks great. I always could find something wrong. And then in blood work, you're looking at a SMAC 40 or, you know, something with 50 numbers on it, and they have nothing to say because the computer didn't say high or low. It's ridiculous. So, in the functional analysis, you've got to know the biochemistry and I'm going to do a little commercial for Ralph. So one of the things that Ralph is particularly good at is seeing the nuances. He is an elegant reader of biochemistry. He knows the details. And so, he's one of the people you probably want to have take a look at it if you can get a hold of him. So I'll tell you how to do that later. So women get this way more than men, and I'm becoming-- I have a men's and women's health clinic. We're doing bioidentical hormones. We're doing, you know, stem cells. We're doing Mesenchymal stem cells. I certainly understand on the biochemical level that women are more complex. Men have five times more testosterone than women, but women take the amount that they have, let's say two units converted into estrogen and then everything else. So we used to think it was, you know, cholesterol to pregnenolone to the sex hormones. That's not actually how it is. We had to relearn it. So women-- and women's brains are different. Like, the women have a smaller brain by one-third, but they have a huge corpus callosum. So, I get it, that men and women are different. I don't get why women get more Alzheimer's than men, do you?

Ralph Sanchez
Yes, I do.

Dr. Thomas Santucci
Oh, okay.

Ralph Sanchez
And it's something that I've spoken about quite a bit. As a matter of fact, I've admired for a long time anyways, has long been a proponent for women and their particular risk for Alzheimer's disease, and she has recently partnered with the Cleveland Clinic and opened up a clinic in Las Vegas. Yeah.

Dr. Thomas Santucci
What's going on with women's chemistry and neurology that makes them more susceptible?

Ralph Sanchez
Well, one of the things as well as with men in a different way, but hormones are huge.

Dr. Thomas Santucci
Right.

Ralph Sanchez
And here's the thing that I write about in my book a little bit, but it's a much bigger topic than I put in the book, and that is one of the central things in the risk for Alzheimer's disease in both men and women, and it has a lot to do with insulin resistance. Okay? Insulin resistance in the body, most people understand, is associated with Type 2 diabetes.

Dr. Thomas Santucci
Right.

Ralph Sanchez
But we have an insulin resistance in the brain. That's the title of my book, you know, "The Diabetic Brain", which is an overview of the Type 3 diabetes model, which is an insulin resistance in the brain. Regardless, as a parallel tract of that is something called glucose hypometabolism.

Dr. Thomas Santucci
Right.

Ralph Sanchez
You're not able to metabolize glucose as an energy substrate in the brain very well under an insulin-resistant state. But in women, that is particularly a problem because estrogen in women-- and this is something that when I discovered in the mid-2000s, bolt of lightning hit my brain, and I thought, oh, my God, this is so huge because I started to see this whole thing regarding a model of brain function and energy metabolism that's called glucose hypometabolism.

Dr. Thomas Santucci
Nice.

Ralph Sanchez
Okay? So you're not able to utilize glucose. Most aging people really have declined in their ability to metabolize glucose as an energy substrate in the brain as they age. And a lot of it has to do with insulin resistance associated with cardiometabolic disease. But in women, an additional risk factor to cardiometabolic disease is estrogen because estrogen governs glucose metabolism in women.

Dr. Thomas Santucci
Nice.

Ralph Sanchez
It's huge. And, as-- not all women but some women have a real precipitous decline in estrogen in menopause.

Dr. Thomas Santucci
Right. Well, the post-menopause are woman thing is almost like a death sentence in terms of osteo and in terms of bone growth. It amazes me getting into this work a little bit. In our women's health clinic, there's no strategy the day you go menopausal. You know, it's like, why aren't we suddenly giving those people bioidentical hormones and getting them on it? And then in that world, there's always politics and obstructions and horrible inertia when you're trying to do a new thing. But in that world, what they did is they basically called all the estrogens progestins, which are the carcinogenic estrogens. So the bioidenticals are linked in with the stuff that will for sure cause cancer. And then they go, oh, that causes cancer. And you go, no, the research actually shows this is good, this is bad. And they go, they're all estrogens. And you're like, right, just lump things together, you'll get the wrong answer. And so, we're finding is that the actual research on estrogen half the time is being done with birth control, which is, you know, an inflammatory progestin, not estradiol, that matches what God made and what humans should have. So in this world, I can definitely see it as an inflammatory mediator, depending on what people are doing. And then the spiking-- you know, when we're talking about sugar handling stress, to do the analogy to the body's blood sugar, you know, when that happens, there's a ton of sugar in the blood, but there's not sugar in the cells. Is that what's happening in the brain?

Ralph Sanchez
Well, the only reason there would be sort of a sugar accumulation problem, as you just referred to, would be the fact that you're not able to metabolize it.

Dr. Thomas Santucci
Right.

Ralph Sanchez
And that leads to another risk factor associated with glycation, which is a big factor in terms of the insulin resistance and elevated blood glucose levels and serum. And that is referred to as the glycation process. That's the primary-- a damage associated with diabetes, where you have these excess sugar floating around and interacting with all the tissues, the proteins, and the fat and causing serious damage, which is called glycation. That's what's happening to the hemoglobin, right? And that's the measure of A1C, hemoglobin A1C. But that's the beginning of that deleterious process is glycation. And then there's advanced glycation end product. And that's a subject that is not discussed enough. And I talk about that in the book. Advanced glycation end products are a serious cardiometabolic risk factor that also is a huge risk factor for your brain.

Dr. Thomas Santucci
Right. So do you have an overall kind of general diet you like? I know you personally are very fit, you're aging very well. You know, for a person that's 50, you don't look in a day over, you're above 70. Let's just say that, well, I'm approaching 70. So I get that. But you're older than I am, but you're compact. You're in good control of your mind and your body. You're obviously cognizant of the nutrition. What do you tell your clients? What do you tell people you work with? Are you going modified Paleo right away, or are you going keto? Or what do you do?

Ralph Sanchez
Well, you know, I think that you would agree that everything you do with a particular person is personalized or should be personalized.

Dr. Thomas Santucci
Sure.

Ralph Sanchez
There's not a universal approach that I use, although most people that I eventually decide to work with, you know, do have some health issues.

Dr. Thomas Santucci
Sure.

Ralph Sanchez
And somewhat in the cardiometabolic range of the spectrum of problems that they might have as they're aging. And so one of the most important interventions is diet.

Dr. Thomas Santucci
Yeah.

Ralph Sanchez
And ketogenic diet may be particularly important to start the ball rolling. I don't recommend ketogenic long-term.

Dr. Thomas Santucci
Sure.

Ralph Sanchez
You know, if people can because here's the other problem associated with these diets, is that people find them very difficult to adhere to.

Dr. Thomas Santucci
Yeah.

Ralph Sanchez
So compliance is a big risk factor. And I try to meet people, you know, halfway as much as possible. But, you know, yes, ketogenic, intermittent fasting, caloric restriction, I've applied those models in my own health care, and I find them to be very powerful.

Dr. Thomas Santucci
Right.

Ralph Sanchez
And they are very, very important in terms of reversing some of the metabolic damage associated with cardiometabolic disease and what's happening to your brain.

Dr. Thomas Santucci
Sure.

Ralph Sanchez
So it's a very important approach, and it has to be integrated into the treatment plan, the program, one way or another.

Dr. Thomas Santucci
Yeah. Now, how about things like phosphatidylcholine serine, phosphatidylcholine, the things that could directly biochemically affect, like the neurotransmitters to the hippocampus. Are you doing those?

Ralph Sanchez
Oh, absolutely.

Dr. Thomas Santucci
Yeah.

Ralph Sanchez
You know, supplementation is very, very important.

Ralph Sanchez
Right.

Ralph Sanchez
Especially in an aging individual. You talked about phosphatidylserine and phosphatidylcholine, you know, those are essential phospholipids that are very, very important for the structure of the cell, the membrane that surrounds the cell.

Dr. Thomas Santucci
Right.

Ralph Sanchez
And that membrane is an important functional and structural element of cellular function and how it works, and the synapse, which is the locus, the communication between these cells, you know, where they meet and communicate, and the phospholipids and omega 3s, particularly DHA, are particularly important in that structure and function. You know, there is a concept in the world of this approach to healthy membrane function, which is called lipid rafts. And these rafts move around. So membrane fluidity is very, very important.

Dr. Thomas Santucci
Right.

Ralph Sanchez
And that's what these fats provide. They provide a--

Dr. Thomas Santucci
Sorry, are you putting everyone on EPA DHA or do you have a fish oil factory?

Ralph Sanchez
Yes.

Dr. Thomas Santucci
We are, too, by the way.

Ralph Sanchez
Yeah. Particularly DHA.

Dr. Thomas Santucci
Yeah.

Ralph Sanchez
You know, EPA can be very important in terms of inflammation, of course. But DHA is anti-inflammatory, too.

Dr. Thomas Santucci
Yeah.

Ralph Sanchez
And it's particularly important for that membrane structure that I just mentioned.

Dr. Thomas Santucci
Right.

Ralph Sanchez
And APOE4 genotypes have a much higher requirement for DHA.

Dr. Thomas Santucci
Do you test for that? Like that's beyond my [inaudible] 

Ralph Sanchez
Oh, you know, there's a very basic test that looks at your EPA DHA. Right?

Dr. Thomas Santucci
Nice.

Ralph Sanchez
The Omega-3 index. That's a very basic, inexpensive test. You can do more advanced testing, Omega-3 fatty acid testing that actually incorporates the Omega-6s Arachidonic acid, and all the other fats that are involved in that metabolic cascade. But, you know, just the Omega-3s all by themselves, you know that ratio. And then understanding where the DHA and EPA are in terms of that ratio is really important, too.

Dr. Thomas Santucci
You know, I don't want to lament the lack of progress, but, you know, the first time I heard that we had way more 9s. And then probably the right amount of 6s or maybe a little too much and not enough 3s. It was 30 years ago, you know.

Ralph Sanchez
Yeah.

Dr. Thomas Santucci
Like, we have not fixed anything in nutrition in this country.

Ralph Sanchez
Yeah. Well, people's awareness certainly has gotten a bit better.

Dr. Thomas Santucci
Yeah.

Ralph Sanchez
And that's good. But you mentioned Omega-9s, you know, olive oil.

Dr. Thomas Santucci
Right.

Ralph Sanchez
You know, and, you know, I'm a big fan of olive oil.

Dr. Thomas Santucci
Me too. Yeah.

Ralph Sanchez
And, you know, it's one of those foods that you just really want to get into your body regularly every day.

Dr. Thomas Santucci
Sure.

Ralph Sanchez
And a good high-quality one. And I think there are some good, high-quality olive oils available here in the US.

Dr. Thomas Santucci
Do you?

Ralph Sanchez
Yeah.

Dr. Thomas Santucci
Because our word is we were getting it from Sicily, you know, and they're saying that it's all been taken over by the mob. And you can't get olive oil from Sicily. And so we're buying Greek olive oil, which tastes like turban [inaudible]. We're getting it from Greece [inaudible].

Ralph Sanchez
Oh, are you?

Dr. Thomas Santucci
But both of those taste green to me. You know, they don't taste like olive oil. So we don't have a good source of olive oil.

Ralph Sanchez
Well, here's a tip on olive oil that I always mention to my patients. First of all, the more bitter it is, the higher the polyphenol content. Okay? So the polyphenolics, these are phytochemicals, naturally occurring chemicals in the plant world. And olive oil isn't the only source.

Dr. Thomas Santucci
Right.

Ralph Sanchez
Fruits and vegetables are a big part of that. And there's a book I haven't published yet. It's called "The Improved Mind Diet". Somewhat modeled after the "Mind Diet". I take it a step further and I say, look, Mediterranean diet, Mind Diet, Ketogenic diet, all great, you know?

Dr. Thomas Santucci
Right.

Ralph Sanchez
But they need to be personalized. And that's what "The Improved Mind Diet" is all about.

Dr. Thomas Santucci
Nice.

Ralph Sanchez
Which is looking at, you know, all these foods and what you may need more so, in terms of your particular need, some things are universal. Right? Fruits and vegetables, olive oil.

Dr. Thomas Santucci
Sure.

Ralph Sanchez
Is rich in polyphenols. And these phytochemicals are incredible in terms of what they do for your body and brain.

Dr. Thomas Santucci
Nice.

Ralph Sanchez
You know they stimulate a transcription factor which is called Nrf2, and then Nrf2 stimulates a whole cascade, a signaling pathway that's associated with the activation of almost 400 genes associated with anti-inflammation, antioxidant, and detoxification.

Dr. Thomas Santucci
Oh, and that's so crucial because what you've done is actually created a real link to something that everybody lists as a generic health factor. You know, we know that half the things that kill you are routed in inflammation. But again, that was the front of Time Magazine 20 years ago.

Ralph Sanchez
Yeah. Yeah.

Dr. Thomas Santucci
Nobody did anything about it. And so now, your [inaudible] it.

Ralph Sanchez
Yeah. It's still a core factor, you know.

Dr. Thomas Santucci
It's huge.

Ralph Sanchez
Like I say in my book, you know, everything boils down to oxidative stress and inflammation, you know. But what are the roots to that? You have to address the roots to that.

Dr. Thomas Santucci
Right.

Ralph Sanchez
You know, the underlying causes of it.

Dr. Thomas Santucci
Sure.

Ralph Sanchez
Otherwise, you're just, you know, treating like conventional medicine. You're just treating the expression.

Dr. Thomas Santucci
Right. Exactly.

Ralph Sanchez
You know, the symptom.

Dr. Thomas Santucci
I love it. So, what was the main message you'd want to give our listeners on taking care of themselves and their families in regard to neuro dementias?

Ralph Sanchez
Well, I have a little model that I use a lot. It's called "think ahead".

Dr. Thomas Santucci
There you go. Anticipation. Love it.

Ralph Sanchez
No, think ahead, you know. If you're in your 40s-- and this is well known, I'll never forget when I first saw this many, many years ago, and I go, well, of course, you know.

Dr. Thomas Santucci
Yeah.

Ralph Sanchez
And now, it's actually quite prevalent in the literature. And that is that midlife is a pivotal point in a person's risk for dementia and Alzheimer's disease later in life. Why? Because of that 20 to 30-year trajectory that I talked about.

Dr. Thomas Santucci
Right.

Ralph Sanchez
So if you're in your late 40s and early 50s, you're probably 20 years away, 15 to 20 years away from a possible diagnosis of dementia or Alzheimer's disease. And that disease process brews as a silent disease process in its preclinical stage.

Dr. Thomas Santucci
Right. It's a [inaudible] 

Ralph Sanchez
In other words, when Alzheimer's starts in the brain, you have no symptoms, you're fine, and you're doing everything normally.

Dr. Thomas Santucci
Right.

Ralph Sanchez
You know, ten years later, you're into a mild cognitive impairment spectrum, and that can last another ten to 15 years.

Dr. Thomas Santucci
Yup.

Ralph Sanchez
Okay? And so that's midlife. You know, so, when you start hitting 50s and early 60s and you're noticing, wow, I'm just not performing as well. That could be a serious risk factor.

Dr. Thomas Santucci
Exactly.

Ralph Sanchez
So looking at your risk factors in midlife is crucial.

Dr. Thomas Santucci
Nice.

Ralph Sanchez
Your cardiometabolic risk factors. You can start looking at cognitive performance.

Dr. Thomas Santucci
Yeah. So most of our listeners should be looking at this, you know, at least by age 50, and, you know, by 60 you should just go look in the mirror and see how many times you walked in the room and ask yourself, why did you walk in the room? Or where your keys are, or what the name of that person you couldn't remember is? You know, and so, I mean, we all have those moments, but there really is a time and a place where this is not frontal lobe, it's not cognition. That's one of the problems. It's not judgment per se. This is hippocampal. It's the memory center. The memory is as complicated as anything in the brain is. It's really one of the big-- we don't really know because we think it's holographic, but then we know it's in the hippocampus, but then we're not sure. So, you know, at the end of it. And then is it neurochemical? Is it structural? Is it synaptic? We don't know that either, really, but we certainly have strong feelings about this. So, you look at it and then you just say, should I be spending some of my time with brain health? Should I be doing something to make sure that when I'm 80 and I sense the reality that I process it right, that my body's controlled right, and that my thoughts have proper amounts of history, memory, and current information and that I'm living my fullest life? And I think when you put it as like we have that be the bar. Yes, I made it through. And I don't drill when I eat. You know, that's not the bar, because we can do that instinctively. And so, when you actually are putting it out there that says you want to continue with high performance and it's not serendipity, it's not, oh, it'll just happen if it happens. It happens if you make it happen. And I've heard this story from so many people. We see it when we take a person who's, like, in a ten-foot hole in the ground, we get them up to sea level, then we do it again. And we do it again. Well, some of these people like you, Ralph, that have really been in trouble with their health and really had a big challenge, and they're 75, they're way better than regular people. Our seven-year-olds are looking like 50-year-olds. I think it's a mixed blessing to have health challenges early that you overcome, but I think in this busy time and day, saying prevention is almost-- for one, it's cliche, but also you're going to take resources from the current person's life. It's a hard sell. You know, I applaud you in your effort to like do that with your life. Again, you're way more patient than I am. I think it's a thing that's going to turn into probably one of the most vital services that we can do to help each other. I'm going to put Ralph's contact information, and Ralph is an amazing coach. He's a really gifted biochemist. He's an elegant individual. He knows a lot about energy medicine, and he's an expert on this subject. And I appreciate your time and attention and your expertise.

Ralph Sanchez
Thank you for having me. It was a pleasure having to spend a little time with you, too.

Dr. Thomas Santucci
Yeah.

Ralph Sanchez
And talking about my favorite topic.

Dr. Thomas Santucci
Perfect. All right, you all have a good day.

Ralph Sanchez
Thank you, Thomas.

Dr. Thomas Santucci
Bye bye.

Outro
Thanks for listening to "The Medical Insider" podcast. If you enjoyed today's episode, make sure you visit "themedicalinsider.com". Go ahead and sign up for these episodes. Get them sent directly to your inbox. Do us a favor and give us a "Like".